Total assets of BioNTech 2017-2023
On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end. In 2023, total assets of biotech company BioNTech SE stood at some 23 billion U.S. dollars, a decrease from around 23.3 billion dollars in 2022. This statistic illustrates the total assets of BioNTech SE from 2017 to 2023.